Polymorphisms in the TGF- β1 (rs1982037) and IL-2 (rs2069762, rs4833248) genes are not associated with inhibitor development in Iranian patients with hemophilia A.
CONCLUSIONS: Regarding our results in molecular predisposition for inhibitor development, further studies of effective genetic markers are required as a prerequisite for the development of novel immunogenic therapeutic approaches in the future.
PMID: 29993342 [PubMed - as supplied by publisher]
Source: Hematology - Category: Hematology Tags: Hematology Source Type: research
More News: Genetics | Haemophilia | Hematology | Hemophilia | Iran Health | Middle East Health | Statistics | Study